Correction: Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-0351
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas

Laryngoscope
Otorhinolaryngology
2011English

Neo-Adjuvant Chemotherapy Alone or With Regional Hyperthermia for Soft-Tissue Sarcoma

The Lancet Oncology
Oncology
2017English

Trabectedin in the Treatment of Patients With Soft Tissue Sarcoma

Nowotwory
Cancer ResearchOncology
2018English

New Drugs and Combinations for the Treatment of Soft-Tissue Sarcoma: A Review

Cancer Management and Research
Oncology
2012English

Treatment of Pelvic Bone and Soft Tissue Sarcoma.

Orthopedics & Traumatology
1997English

Role of Trabectedin in the Treatment of Soft Tissue Sarcoma

OncoTargets and Therapy
OncologyPharmacology
2009English

Epigenetic Modulation With Oral Histone Deacetylase (HDAC) Inhibitor as a New Treatment Option in JIA

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy